Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement

Taryn A. G. Quinlan, Brock Schroeder, Sue Kwon, Jane F. Barlow, Michael S. Sherman, Heather D. Anderson, Garth Wright and R. Brett McQueen ()
Additional contact information
Taryn A. G. Quinlan: University of Colorado Anschutz Medical Campus
Brock Schroeder: Illumina, Inc.
Sue Kwon: University of Colorado Anschutz Medical Campus
Jane F. Barlow: Real Endpoints, LLC
Michael S. Sherman: Harvard Pilgrim Health Care
Heather D. Anderson: University of Colorado Anschutz Medical Campus
Garth Wright: University of Colorado Anschutz Medical Campus
R. Brett McQueen: University of Colorado Anschutz Medical Campus

PharmacoEconomics - Open, 2021, vol. 5, issue 3, No 9, 449-458

Abstract: Abstract Background Harvard Pilgrim Health Care expanded coverage for non-invasive prenatal testing (NIPT) to include all pregnant, single-gestation women aged

Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s41669-021-00261-y Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-021-00261-y

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/41669

DOI: 10.1007/s41669-021-00261-y

Access Statistics for this article

PharmacoEconomics - Open is currently edited by Timothy Wrightson and Christopher Carswell

More articles in PharmacoEconomics - Open from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().